SCHEMBL6952166

SCHEMBL6952166

COc1ccc(COC2CN(OC(=O)OC(C)(C)C)CCC2c2ccc(F)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
REN P00797 3/20 0.41
RXFP1 Q9HBX9 1/20 0.38
KDM1A O60341 1/20 0.38
MAOB P27338 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
FPR2 P25090 2/20 0.37
FFAR1 O14842 1/20 0.37
HTR2A P28223 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
FPR1 P21462 1/20 0.36
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954247 0.92 REN (0.42) RENKDM1AKMT2AMEN1HTR2A
SCHEMBL6954378 0.91 REN (0.41) RENKDM1AKMT2AMEN1L3MBTL1
SCHEMBL6960467 0.91 ALDH1A1 (0.43) RENL3MBTL1
SCHEMBL6949602 0.88 GPR119 (0.39) KDM1AMAOBKMT2AMEN1
SCHEMBL6955914 0.87 GPR119 (0.43)
SCHEMBL7078323 0.86 REN (0.45) RENMCHR1
SCHEMBL7074891 0.85 REN (0.48) REN
SCHEMBL6959366 0.85 CCR2 (0.41) KMT2AMEN1MCHR1
SCHEMBL7076957 0.85 MC4R (0.36) RENKDM1AMAOB
SCHEMBL6959336 0.84 KMT2A (0.39) MAOBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed